BioCentury
ARTICLE | Clinical News

CT Atlantic preclinical data

April 25, 2011 7:00 AM UTC

In mouse models of colorectal cancer, CTA001.12D7 plus 5-fluorouracil (5-FU) significantly reduced tumor size vs. 5-FU alone (p<0.0001). CTA001.12D7 is a human mAb against cancer/testis antigen 1B ( ...